Clinical trial
The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide…
NCT00321321 · University Hospital, Gentofte, Copenhagen, Other · Completed
Key facts
| NCT number | NCT00321321 |
|---|---|
| Title | The Beta Cell Responsiveness to Glucose-dependent Insulinotropic Polypeptide (GIP) With and Without Sulfonylurea in Patients With Type 2 Diabetes |
| Official title | Phase 2 Study of The Beta Cell Responsiveness to GIP With and Without Sulfonylurea in Patients With Type 2 Diabetes |
| Lead sponsor | University Hospital, Gentofte, Copenhagen, Other |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Diabetes Mellitus, Type 2 |
| Intervention type | Drug |
| Interventions | Sulfonylurea |
| Enrollment | 12 |
| Start date | May 1, 2006 |
| Primary completion | Mar 1, 2007 |
| Completion | Apr 1, 2007 |
| First posted | May 3, 2006 |
| Last update posted | Jul 16, 2015 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: